A clear divide in drug control approaches became apparent at the end of the High Level Segment of the Commission on Narcotic Drugs (CND) on March 11-12 in Vienna, where countries gathered to review to progress since the 1998 UN General Assembly Special Session (UNGASS) and set a framework for the next 10 years through a Political Declaration and Plan of Action.
At one side of the divide a growing number of countries opt for pragmatic evidence-based harm reduction policies, while at the other side countries desperately cling to a zero tolerance approach that has failed to produce any significant result the past decade. Despite the diplomatic façade, the conclusion cannot be otherwise that the Vienna consensus on drug control that has paralysed progress in international drug control for decades, has fallen apart.
Marco Perduca and Donatella Poretti, senators of the Radical Party have asked the Italian under-secretary on drug issues, Carlo Giovanardi, if it is true that Italy has abandoned the common position of the European Union on harm reduction in the negotiations for the Political Declaration for the High-level Segment of the 52nd Commission on Narcotic Drugs (CND) in Vienna. They requested an explanation from the under-secretary why and on what grounds this happened.
The Hungarian Civil Liberties Union (HCLU) made some interesting video news items on the Commission on Narcotic Drugs. In this one leading civils society spokespersons comment Mr. Costa, the UNODC Executive Director, opening speech. Costa's opening speech was somewhat surprising in that he coincided on some points that have been raised by civil society groups over the past years. He stressed that too many people in prison, and too few in health services; that there are too few resources for prevention, treatment, and rehabilitation; and that there is too much eradication of drug crops, and not enough eradication of poverty.
The Executive Director of UNAIDS, Michel Sidibé, wrote a letter to the delegates negotiating the Political Declaration for the 52nd session of the UN Commission on Narcotic Drugs (CND) in Vienna on March 11-12, 2009, dedicated to review of the progress achieved and the difficulties encountered by in meeting the goals and targets set out in the 1998 UNGASS.
Conflicting views and policies within the UN system on harm reduction have become a major concern. Consistency in messages is crucial especially where it concerns joint global programmes such as the efforts to slow down the HIV/AIDS epidemic; efforts in which harm reduction practices like needle exchange and substitution treatment play a pivotal role.
The US pressure on the UNODC to withdraw support from needle exchange and other harm reduction approaches backfired at the 48th session of the CND in March 2005. Delegates from around the globe stood up to defend the overwhelming evidence that harm reduction measures are effective against the spread of HIV/AIDS. In this briefing TNIanalyses the proceedings and results of the CND meeting in Vienna in March 2005, and outlines several options for follow-up and recommends next steps to take.
“We will be aiming for no less than securing the inclusion of harm reduction in the political declaration by which member states determine international drugs policy,” the Dutch Minister for Development Cooperation Bert Koenders told the Donor Conference on Harm Reduction that took place on January 28-30, 2009, in Amsterdam. “We will do the same when, in 2010, the honour of chairing the UNAIDS governing board falls to the Netherlands. You can count on that.”
"We respectfully urge you to support syringe exchange, opiate substitution treatment and other harm reduction approaches demonstrated to reduce HIV risk; to affirm the human rights of drug users to health and health services; and to reject efforts to overrule science and tie the hands of those working on the front lines."
In this open letter to the Commission on Narcotic Drugs, 334 organisations express their concern about U.S. efforts to force a UNODC retreat from support of syringe exchange and other measures proven to contain the spread of HIV among drug users.
The Bush administration is quietly extending a policy that undermines the global battle against AIDS. "The State Department's new leadership needs to end this bullying flat-earthism. It won't help President Bush's current effort to relaunch his image among allies. And it's almost certain to kill people."
It is still not clear what the drug policy of President Obama will be. He has not appointed his drug czar. Many high-ranking Bush Administration officials have yet to leave office and are still setting the agenda on drug policy.
The US delegation in Vienna continues to block any inclusion of harm reduction in the new Political Declaration – to be approved in March 2009 at the high-level segment of the 52nd session of the Commission on Narcotic Drugs. Three members of the US Congress have written a letter to the new US Ambassador to the UN, Susan Rice, to call for new instructions to be given to the delegation.
The Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, urged the president of the UN Commission on Narcotic Drugs (CND) to send a strong message to the world with clear and specific language that calls for comprehensive harm reduction services.
The Obama White House announced today that the new President supports lifting the federal ban on needle exchange, which could dramatically reduce rates of HIV/AIDS infection among drug users. Will he also lift the ban on the concept of harm reduction, which has paralysed the international drug policy debate under his predecessors?
Allan Clear of the Harm Reduction Coalition made an urgent appeal on the Obama White House to intervene in the current negotiations about the Political Declaration on the 1998 UNGASS review that has to be adopted in March 2009 at the High Level Segment of the Commission on Narcotic Drugs (CND). For more than two million people living with HIV, mainly in Africa, hopes are high for a change in Obama's foreign policy.
Peter Reuter (RAND), Franz Trautmann (Trimbos Institute) (eds.)
15 March 2009
This report commissioned by the European Commission, found no evidence that the global drug problem has been reduced during the period from 1998 to 2007 – the primary target of the 1998 UNGASS, which aimed to significantly reduce the global illicit drugs problem by 2008 through international cooperation and measures in the field of drug supply and drug demand reduction. Broadly speaking the situation has improved a little in some of the richer countries, while for others it worsened, and for some of those it worsened sharply and substantially', among which are a few large developing or transitional countries. Given the limitations of the data, a fair judgment is that the problem became somewhat more severe.
A useful overview of UN endorsement of harm reduction measures; the legality of harm reduction services under the Drug Conventions; the obligation in human rights law to ensure access to harm reduction services and the global state of harm reduction, listing 82 countries and territories worldwide that presently support or tolerate harm reduction.